US2008058371A1PendingUtilityA1
Stabilized difloxacin injectable solution
Est. expiryJan 28, 2022(expired)· nominal 20-yr term from priority
Inventors:Henderik Willem Frijlink
A61P 31/04A61K 31/4709A61K 47/183A61K 31/495A61K 47/10
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An antibacterial formulation suitable for injection into animals containing approximately 2-10% w/v difloxacin HCl, L-arginine base, propylene glycol, ethanol and/or benzyl alcohol, and water. The formulation is a solution having a pH of form 9 to 10. The formulation produces little or no tissue damage or irritation at the injection site.
Claims
exact text as granted — not AI-modified1 - 8 . (canceled)
9 . (canceled)
9 . (canceled)
10 - 14 . (canceled)
15 : A method of treating a bacterial infection in an animal in need thereof comprising the step of administering to the animal by injection a therapeutically effective amount of a pharmaceutical composition comprising about 2-10% w/v difloxacin HCl; 5-20% w/v L-arginine base; about 5-15% w/v ethanol; up to about 10% w/v of an anti-microbial preservative; propylene glycol, glycerol, a soluble polyethylene glycol, or a combination thereof; and water, wherein said composition has a pH in the approximate range of 9-10.
16 : The method according to claim 15 , wherein the composition comprises about 4-6% w/v difloxacin HCl.
17 : The method according to claim 16 , wherein the composition comprises approximately 20-40% propylene glycol and 5-15% L-arginine base; and the anti-microbial preservative is selected from the group consisting of benzyl alcohol, phenol, chlorocresol and a mixture thereof.
18 : The method according to claim 15 , wherein the pH of the composition is in the approximate range of 9.1-9.6.
19 : The method according to claim 16 , wherein the pH of the composition is in the approximate range of 9.1-9.6.
20 : The method according to claim 17 , wherein the pH of the composition is in the approximate range of 9.1-9.6.
21 : The method according to claim 17 , wherein the preservative of the composition is benzyl alcohol.
22 : The method according to claim 15 , wherein the composition further comprises potassium hydroxide.
23 : The method according to claim 22 , wherein the preservative of the composition is benzyl alcohol and the pH of the composition is in the approximate range of 9.1-9.6.
24 : A method of treating a bacterial infection in an animal in need thereof comprising the step of administering to the animal by injection a therapeutically effective amount of a pharmaceutical composition comprising about 5% w/v difloxacin HCl; 10% w/v L-arginine base; about 10% w/v ethanol; about 5% w/v benzyl alcohol; about 30% w/v propylene glycol; and water, wherein said composition has a pH in the approximate range of 9.1-9.6.Join the waitlist — get patent alerts
Track US2008058371A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.